Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-11,850
Closed -$2.19M 3
2018
Q2
$2.19M Sell
11,850
-1,320
-10% -$233K 4.76% 3
2018
Q1
$2.25M Buy
13,170
+2,505
+23% +$460K 4.51% 4
2017
Q4
$1.85M Buy
10,665
+100
+0.9% +$17.7K 3.56% 11
2017
Q3
$1.97M Sell
10,565
-500
-5% -$88.6K 3.81% 9
2017
Q2
$1.91M Hold
11,065
3.69% 8
2017
Q1
$1.81M Buy
11,065
+270
+3% +$44.9K 3.52% 9
2016
Q4
$1.58M Buy
10,795
+645
+6% +$97.1K 3.22% 10
2016
Q3
$1.69M Buy
10,150
+1,475
+17% +$249K 3.32% 11
2016
Q2
$1.32M Buy
8,675
+700
+9% +$109K 2.79% 16
2016
Q1
$1.2M Buy
7,975
+4,135
+108% +$614K 2.62% 14
2015
Q4
$623K Buy
3,840
+1,340
+54% +$211K 1.5% 26
2015
Q3
$346K Buy
+2,500
New +$394K 0.87% 36

Other funds holding AMGN

P.R. Herzig & Co's AMGN Position: Q3 2018 in Review

P.R. Herzig & Co sold out of Amgen (AMGN) in Q3 2018, closing a stake of 11,850 shares — an estimated $2.19M sold.

P.R. Herzig & Co first reported a position in AMGN in Q3 2015 and held it in 12 quarters. The position peaked at $2.25M in Q1 2018. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • P.R. Herzig & Co reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
  • P.R. Herzig & Co sold 11,850 Amgen shares in Q3 2018, an estimated $2.19M.
  • P.R. Herzig & Co first reported a position in Amgen in Q3 2015 and held it in 12 quarters.
  • P.R. Herzig & Co's Amgen position peaked at $2.25M in Q1 2018.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on P.R. Herzig & Co's 13F filing for Q3 2018.